Product Hunt 50 Beta Spots Remaining
Loading...

Stop losing hours to
research that goes
nowhere.

Every week, your team misses critical papers, trial updates, and patent filings — because tracking everything manually is impossible. Arxana monitors 200M+ sources and delivers a daily synthesized briefing, ranked by what actually matters to your pipeline.

50 spots open — claim yours free during launch
200M+ papers monitored
AI relevance scoring
Briefing by 8am daily
2 min setup

You can't read everything.
Your competitors can.

Your team is spending 20+ hours/week on literature reviews that go stale the moment they're done. Meanwhile, critical signals — a new trial enrolling in your indication, a competitor's patent filing, an unexpected safety signal — slip through the cracks.

  • Keyword alerts are noisy — 90% irrelevant, 10% too late
  • arXiv + PubMed + ClinicalTrials.gov don't talk to each other
  • Research updates arrive faster than any human can process
  • Competitive intel lives in Slack threads, not in your briefing
Arxana Daily Briefing — May 24, 2026
3 signals worth your time today
97 Phase III Trial
Novartis reports positive Phase III data for CDK4/6 inhibitor in early-stage breast cancer — first-in-class mechanism
Relevance: 2 pipeline assets in your oncology portfolio target adjacent pathways. Potential competitive overlap within 18 months.
91 Patent Filing
Roche files new IP for bispecific antibody construct targeting HER2 + PD-L1
Relevance: Directly competes with your HER2 pipeline. Filing covers 14 jurisdictions including key EU markets.
78 Preprint
Stanford team publishes preprint on AI-guided patient stratification for immunotherapy response
Relevance: Methodology applicable to your current trial design. Authors open to collaboration.

From signal to decision in three steps.

01

Connect your research

Add your domains, competitors, therapeutic areas, or key authors. Takes 2 minutes. Runs forever.

02

AI monitors daily

Arxana scans PubMed, arXiv, clinical trials, and patent databases every 24 hours — connecting signals that siloed tools miss.

03

Get synthesized briefings

Every morning: what's new, why it matters, and what to do about it. Not a list of links — actual intelligence.


Coverage built for serious research teams.

200M+
Papers & preprints tracked
500K
Active clinical trials monitored
3.5M
Patents scanned annually
4
Sources unified in one platform

What early access teams are saying.

We replaced our weekly PubMed search with Arxana briefings. The AI ranking is uncannily accurate — the top paper almost always turns out to be the one we end up citing in our next grant. Saves my postdoc about 8 hours a week.
MK
Dr. Megan Kim
Principal Investigator, Oncology — NexusBio
The patent monitoring alone is worth the subscription. We caught a competitor filing 6 months earlier than our previous workflow would have. That kind of head start changes board conversations.
JL
James Liu
VP Research, Kestrel Therapeutics

One platform. Every source.

📄
Papers & Preprints
PubMed, arXiv, bioRxiv
🔐
Clinical Trials
ClinicalTrials.gov, WHO ICTRP
📋
Patents
USPTO, EPO, WIPO
Regulatory
FDA, EMA filings

Per-team pricing. No per-seat surprises.

One subscription covers your entire team. Beta pricing locked for life — upgrade anytime.

Starter
$99/mo
per team

  • 5 team members
  • 5 research targets
  • Daily email briefings
  • Papers & preprints coverage
  • 7-day history
  • Patents & trials (Pro+)
Enterprise
$399/mo+
per team

  • Unlimited members & targets
  • Full coverage (papers, patents, trials, regulatory)
  • Briefings via email + Slack/Teams
  • REST API access
  • SLA + dedicated support

All plans billed monthly. Beta subscribers lock their rate for 12 months. Annual plans available — 2 months free.


Stop reading 200 papers a week.
Let Arxana do it for you.

50 beta spots remaining. Early access opens May 30 on Product Hunt — we ship your access within 24 hours of signup.